Randall Urban, MD
Vice President for Research &
Chief Research Officer

Dr. Randall Urban

Dr. Randall Urban leads a diverse research community in the bold mission to improve medical practice through progressive translational research endeavors. He has 145 peer-review publications, is the Principal Investigator of UTMB's Clinical and Translational Science Award, and has 3 major research interests funded by the NIH and private foundations. In addition to Vice President for Research and Chief Research Officer, Dr. Urban is Vice Dean for Clinical Research in the John Sealy School of Medicine, Professor of Internal Medicine, Director of the Institute for Translational Sciences, and Fellow, John P. McGovern Distinguished Chair in Oslerian Medicine.

Strategic Research Plan

The Strategic Research Plan, which is used by leadership to  develop a path forward through goals, objectives and tactics, has broad input. It includes six integrated health communities that bring together researchers, educators, clinicians and community members to use prevention and treatment to transform illness to health. Read more.

researchfundingbadges
Research Funding
Awards Processed
Lab Space
See more research facts and figures online

RESEARCH ANNOUNCEMENTS

 


 


RESEARCH NEWS


UTMB among top 2 percent in NIH funding

The University of Texas Medical Branch is in the top 2 percent of research institutions receiving funding from the National Institutes of Health moving up in the latest rankings released by the Blue Ridge Institute for Medical Research.  

Overall, UTMB, which received $156,878,411 in grants from the NIH in 2020 -2021, ranked 61 out of 2,849 research institutions. UTMB’s individual schools were also ranked. This was the first year the School of Nursing made the rankings, coming in at 44 out of 89 institutions ranked. The John Sealy School of Medicine was ranked 41 out of 144 institutions and the School of Health Professions came in at 26 out of 84 intuitions.

“These rankings represent a commitment to UTMB’s mission to pursue cutting-edge research to improve the health of Texans and those around the world,” UTMB Interim President Charles Mouton said. “It represents the collaborative efforts of researchers, local donors, and the state of Texas to bring the best minds and best resources to this state.”

Most of the university’s basic and clinical science programs also moved up on the list released by the Blue Ridge Institute for Medical Research, a nonprofit organization that ranks US research institutions by NIH grant awards each year. The NIH is the largest public funder of biomedical research in the world. The Blue Ridge rankings are determined by the whole value of NIH awards to a principal investigator’s institution and do not include research and development contracts or funding from sources other than the NIH.

UTMB remains the number one recipient of NIH research funding in microbiology/immunology/virology and is number two in biochemistry. Other disciplines that received more NIH grant money include anesthesiology, neurology, neurosciences, obstetrics and gynecology, pharmacology and public health and preventative medicine.

“Our improvement in the Blue Ridge rankings demonstrates the outstanding work that our research scientists are doing throughout our university,” Mouton said.  “It signifies the confidence that the NIH puts in our faculty and staff to answer the important questions necessary to improving the health of our state, nation, and the world.”